A Case of Primary Intracranial Sarcoma, DICER1-Mutant, in a Child with a Germline DICER1 Mutation
暂无分享,去创建一个
[1] H. Vuong,et al. A systematic review of the clinicopathological features and prognostic outcomes of DICER1-mutant malignant brain neoplasms. , 2022, Journal of neurosurgery. Pediatrics.
[2] S. Pfister,et al. Primary central nervous system sarcoma with DICER1 mutation—treatment results of a novel molecular entity in pediatric Peruvian patients , 2021, Cancer.
[3] D. Stewart,et al. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma , 2021, Modern Pathology.
[4] D. Kessler,et al. Stopping the beating heart of cancer: KRAS reviewed. , 2021, Current opinion in structural biology.
[5] J. Tímár,et al. Molecular epidemiology and diagnostics of KRAS mutations in human cancer , 2020, Cancer and Metastasis Reviews.
[6] K. Ligon,et al. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin‐like enhancer 1 in primary intracranial sarcoma, DICER1‐mutant , 2020, Histopathology.
[7] W. Foulkes,et al. DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor , 2020, Modern Pathology.
[8] W. Foulkes,et al. An update on the central nervous system manifestations of DICER1 syndrome , 2019, Acta Neuropathologica.
[9] David T. W. Jones,et al. Primary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1 , 2019, Acta Neuropathologica.
[10] David T. W. Jones,et al. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations , 2018, Acta Neuropathologica.
[11] S. Bens,et al. Multiple DICER1‐related tumors in a child with a large interstitial 14q32 deletion , 2018, Genes, chromosomes & cancer.
[12] Gretchen M. Williams,et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model , 2018, F1000Research.
[13] C. Hawkins,et al. Successful treatment of primary intracranial sarcoma with the ICE chemotherapy regimen and focal radiation in children. , 2016, Journal of neurosurgery. Pediatrics.
[14] Gretchen M. Williams,et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model. , 2015, F1000Research.
[15] W. Foulkes,et al. DICER1: mutations, microRNAs and mechanisms , 2014, Nature Reviews Cancer.
[16] Trevor J Pugh,et al. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences , 2014, Oncogene.
[17] Gretchen M. Williams,et al. DICER1 Mutations in Familial Pleuropulmonary Blastoma , 2009, Science.